Ayres J G, Thompson R A
Chest Research Institute, Birmingham Heartlands Hospital, U.K.
Respir Med. 1997 Sep;91(8):464-9. doi: 10.1016/s0954-6111(97)90111-6.
Serum total immunoglobulin (G, A, M and E) and IgG subclass levels were studied in 23 patients with brittle asthma, 23 age- and sex-matched patients with mild asthma and 33 patients with recurrent infective exacerbations of their asthma. Patients with brittle asthma showed significantly reduced levels of IgG (mean +/- SD, 8.8 +/- 3.3 g l-1) compared to patients with mild asthma (11.0 +/- 2.5 g l-1) (P < 0.008) with further significant reductions in the brittle compared to the mild group in IgG1 (5.2 vs 6.3, P = 0.035), IgG2 (2.4 vs 3.25, P < 0.006), IgG3 (0.39 vs 0.55, P < 0.05) and IgA (1.91 vs 2.38, P < 0.03). There were no significant differences between the brittle group and the group with recurrent infective exacerbations for any parameter, but the latter group showed significantly reduced levels of IgG (8.2, P < 0.001), IgG1 (4.9, P < 0.00001) and IgG2 (2.5, P < 0.02) compared to the mild group. In all groups, there was no relationship between dose of inhaled steroids and levels of any antibody. These findings suggest that the presence of a mild degree of humoral immunodeficiency relates to severity of asthma, and suggests that immunoglobulin replacement therapy may be appropriate in patients with the more severe forms of asthma.
对23例脆性哮喘患者、23例年龄和性别匹配的轻度哮喘患者以及33例哮喘反复感染加重患者的血清总免疫球蛋白(G、A、M和E)及IgG亚类水平进行了研究。与轻度哮喘患者(11.0±2.5 g/L)相比,脆性哮喘患者的IgG水平显著降低(均值±标准差,8.8±3.3 g/L)(P<0.008),与轻度组相比,脆性组的IgG1(5.2对6.3,P = 0.035)、IgG2(2.4对3.25,P<0.006)、IgG3(0.39对0.55,P<0.05)和IgA(1.91对2.38,P<0.03)进一步显著降低。脆性组与反复感染加重组在任何参数上均无显著差异,但与轻度组相比,后一组的IgG(8.2,P<0.001)、IgG1(4.9,P<0.00001)和IgG2(2.5,P<0.02)水平显著降低。在所有组中,吸入性类固醇剂量与任何抗体水平之间均无关联。这些发现表明,轻度体液免疫缺陷的存在与哮喘的严重程度相关,并提示免疫球蛋白替代疗法可能适用于更严重形式的哮喘患者。